Wave Life Sciences (WVE) Current Leases (2015 - 2026)
Wave Life Sciences' (WVE) quarterly Current Leases came in at $3.5 million in Q2 2026, down 56.88% YoY from $8.1 million in Q2 2025, and down 57.88% on a QoQ basis from $8.3 million in Q1 2026.
Wave Life Sciences (WVE) Current Leases (2015 - 2026) Analysis & Trends
Wave Life Sciences (WVE) has 11 years of Current Leases data on file, last reported at $3.5 million in Q2 2026.
- Quarterly Current Leases fell 56.88% year-over-year to $3.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.5 million (down 56.88% YoY) and the FY2025 annual result came in at $8.4 million, up 9.47% from the prior year.
- Current Leases eased to $3.5 million in Q2 2026, from $8.3 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $8.4 million in Q3 2025 to a low of $3.5 million in Q2 2026.
- A 5-year average of $6.6 million and a median of $6.8 million in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases surged 44.05% — and 2026, when it tumbled 56.88%.
- Tracing WVE's Current Leases over 5 years: stood at $5.5 million in 2022, then increased by 22.16% to $6.7 million in 2023, then climbed by 13.76% to $7.6 million in 2024, then increased by 9.47% to $8.4 million in 2025, then tumbled by 58.04% to $3.5 million in 2026.
- The last three Current Leases figures came in at $3.5 million (Q2 2026), $8.3 million (Q1 2026), and $8.4 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Wave Life Sciences | 1.05 Bn | 677.62 Mn | - | 3.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.51 Mn |
| Mar 31, 2026 | 8.33 Mn |
| Dec 31, 2025 | 8.36 Mn |
| Sep 30, 2025 | 8.39 Mn |
| Jun 30, 2025 | 8.14 Mn |
| Mar 31, 2025 | 7.88 Mn |
| Dec 31, 2024 | 7.64 Mn |
| Sep 30, 2024 | 7.40 Mn |
| Jun 30, 2024 | 7.16 Mn |
| Mar 31, 2024 | 6.94 Mn |
| Dec 31, 2023 | 6.71 Mn |
| Sep 30, 2023 | 6.50 Mn |
| Jun 30, 2023 | 6.29 Mn |
| Mar 31, 2023 | 6.08 Mn |
| Dec 31, 2022 | 5.50 Mn |
| Sep 30, 2022 | 4.93 Mn |
| Jun 30, 2022 | 4.36 Mn |
| Mar 31, 2022 | 5.12 Mn |
| Dec 31, 2021 | 4.96 Mn |
| Sep 30, 2021 | 4.10 Mn |